These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10485639)

  • 41. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 42. Homicide, novel antipsychotics, and non-compliance.
    Mikhail SW; Kennedy HG
    Lancet; 2000 Apr; 355(9210):1189-90. PubMed ID: 10791411
    [No Abstract]   [Full Text] [Related]  

  • 43. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 44. A male case of monosymptomatic hypochondriacal psychosis responding to olanzapine: a case report.
    Ikenouchi A; Terao T; Nakamura J
    Pharmacopsychiatry; 2004 Sep; 37(5):240-1. PubMed ID: 15470804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
    Richou H
    Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894
    [No Abstract]   [Full Text] [Related]  

  • 46. Clozapine-reserpine combination for refractory psychosis.
    Healy DJ; Dalack GW; Meador-Woodruff JH
    Schizophr Res; 1997 Jun; 25(3):259-60. PubMed ID: 9264181
    [No Abstract]   [Full Text] [Related]  

  • 47. Assessment of therapeutic efficacy versus sedation with antipsychotic agents.
    J Clin Psychiatry; 1996 Jun; 57(6):1-12. PubMed ID: 8666557
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and efficacy of risperidone in substance abusers with psychosis.
    Albanese MJ
    Am J Addict; 2001; 10(2):190-1. PubMed ID: 11444160
    [No Abstract]   [Full Text] [Related]  

  • 49. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone.
    Feifel D; Moutier CY; Perry W
    J Clin Psychiatry; 2000 Dec; 61(12):909-11. PubMed ID: 11206594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risperidone: once-daily dosage.
    Gupta S; Droney T
    Ann Clin Psychiatry; 1996 Dec; 8(4):221. PubMed ID: 8986319
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of schizophrenia with antipsychotics in combination.
    Waring EW; Devin PG; Dewan V
    Can J Psychiatry; 1999 Mar; 44(2):189-90. PubMed ID: 10097844
    [No Abstract]   [Full Text] [Related]  

  • 52. Risperidone for the treatment of psychosis associated with neurosarcoidosis.
    Popli AP
    J Clin Psychopharmacol; 1997 Apr; 17(2):132-3. PubMed ID: 10950486
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of risperidone on prolactinoma growth in a psychotic woman.
    Pal JK; Sarino WA
    Psychosom Med; 2000; 62(5):736-8. PubMed ID: 11020104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of risperidone in psychosis associated with Huntington's disease.
    Madhusoodanan S; Brenner R
    Am J Geriatr Psychiatry; 1998; 6(4):347-9. PubMed ID: 9793585
    [No Abstract]   [Full Text] [Related]  

  • 55. Chemotherapy-induced acute psychosis in a patient with malignant germ cell tumour.
    Puangthong U; Pongpirul K
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25858936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A dose-outcome analysis of risperidone.
    Love RC; Conley RR; Kelly DL; Bartko JJ
    J Clin Psychiatry; 1999 Nov; 60(11):771-5. PubMed ID: 10584767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of mania by risperidone resistant to mood stabilizers.
    Barkin JS; Pais VM; Gaffney MF
    J Clin Psychopharmacol; 1997 Feb; 17(1):57-8. PubMed ID: 9004061
    [No Abstract]   [Full Text] [Related]  

  • 58. Monosymptomatic hypochondriacal psychoses: a diagnostic entity which may respond to pimozide.
    Munro A
    Can Psychiatr Assoc J; 1978 Nov; 23(7):497-500. PubMed ID: 709499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monosymptomatic hypochondriacal psychosis or tardive dystonia?
    Aukst-Margetić B; Margetić B
    J Clin Psychiatry; 2006 Feb; 67(2):328-9; author reply 329. PubMed ID: 16566636
    [No Abstract]   [Full Text] [Related]  

  • 60. Prognosis of a brief psychotic episode.
    Furukawa TA
    Evid Based Ment Health; 2014 Aug; 17(3):81-2. PubMed ID: 25043433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.